Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls.
Patients And Methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age: 23.4±7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay.
Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients.
Conclusion: Our study results suggest that factor H expression can be dysregulated in jSLE patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791549 | PMC |
| http://dx.doi.org/10.46497/ArchRheumatol.2022.9217 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus.
Lupus Sci Med
January 2025
Department of Child Health and Diseases, Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Istanbul, Türkiye
Objective: Juvenile SLE (jSLE) is an autoimmune disease characterised by the presence of high levels of autoantibodies, predominantly targeting nuclear antigens, resulting in a breakdown of self-tolerance. However, its pathogenesis is multifactorial and poorly understood. The aim of this study was to evaluate the potential of nuclear factor-kappa B (NF-κB) and peroxisome proliferator-activated receptor-gamma (PPAR-γ) as biomarkers for jSLE.
View Article and Find Full Text PDFJuvenile lupus-like with negative serology: a clinical dilemma and diagnostic challenge.
J Rheum Dis
January 2025
Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Systemic lupus erythematosus (SLE) is an autoimmune disorder that can affect various organs. Juvenile-onset SLE (jSLE) may be more severe than the adult-onset form, but the diagnosis and classification remain challenging due to the complex nature of the condition and its resemblance to other conditions. Antinuclear antibodies (ANA) are the immunological hallmark of SLE, but their limited specificity poses challenges.
View Article and Find Full Text PDFElevated serum interferon-α2 associates with activity and flare risk in Juvenile-onset Systemic Lupus Erythematosus.
Rheumatology (Oxford)
November 2024
Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, UK.
Article Synopsis
- This study focused on serum IFN-α2 as a potential marker for disease activity and flare prediction in juvenile systemic lupus erythematosus (jSLE).
- Researchers analyzed 222 serum samples from jSLE patients, healthy controls, and juvenile idiopathic arthritis patients to compare IFN-α2 levels across groups and assess its predictive value for disease flares.
- The results indicated that higher IFN-α2 levels were associated with active disease states and could predict flare risk in jSLE patients, suggesting its utility for monitoring and managing the condition.
An Unusual Presentation of Juvenile Systemic Lupus Erythematosus.
Cureus
October 2024
Dermatology, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, USA.
Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organ systems that often mimic other conditions. The majority of patients with SLE show mucocutaneous manifestations, fatigue, fever, rheumatological manifestations, and weight loss as initial symptoms. SLE is classically managed medically with hydroxychloroquine, glucocorticoids, and/or immunosuppressives.
View Article and Find Full Text PDFContributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.
Rheumatology (Oxford)
October 2024
Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Background: Awareness of paediatric-specific predictors of damage in Childhood-lupus is needed to inform mitigation measures.
Objectives: To ascertain how clinical and demographic variables correlate with damage accrual and identify predictors of damage.
Methods: Analysis included UK JSLE Cohort Study participants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!